| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.085 | 0.2 |